Market Access in Medical Technology
2019 · Tino Schubert & Tobias Vogelmann — Practical guidance on approval and reimbursement for market access strategies in medical technology – with checklists, first-hand insights and clear market analysis.
Cases&ClientProjects
Selected cases show how LinkCare translates complex market access, reimbursement and care questions into robust strategies and workable next steps.
Value Demonstration
Health economic modelling for NHS market access
For the NHS market entry of a new cartilage cell therapy, LinkCare developed a Markov model over the patient lifetime and proved the cost-effectiveness despite the lack of long-term studies.
View case
Patient Access & Reimbursement
Market development for a product with an innovative delivery approach
For a minimally invasive ophthalmology product, LinkCare developed a go-to-market strategy after sales volume and revenue had declined sharply since 2022.
View case
Evidence Generation
Retrospective analysis of patient data as a building block for long-term cost coverage
A second-line treatment for patients who had undergone a lung transplant was reimbursed in Switzerland on a temporary basis. There was a lack of data on how the treatment was being used in everyday clinical practice in Switzerland and which patients were benefiting from it. To address this, the * LinkCare * conducted a retrospective cohort study in collaboration with a Swiss transplant centre.
View case
Testimonials&Publications
You can find a selection of the topics on the following pages:
Consultant of the year in manager magazin
Manager Magazin
In 2021, manager magazin listed LinkCare as Consultant of the Year in size category A of the TOP CONSULTANT competition.
LinkCare has been successfully supporting us on complex market access projects for many years. They combine professional excellence, a high level of credibility within the healthcare sector and an exceptional ability to bring together experts from different disciplines to reach viable, consensus-based solutions. The combination of strategic thinking, professional facilitation and strong operational execution makes LinkCare a valued and trusted partner for us.
Manuela Gassner-Oser
Market Access & Government Affairs Director Central Europe
Smith & Nephew GmbH
Consulting in the healthcare sector
2019 / 2020 · Mario A. Pfannstiel, Christoph Rasche, Andrea Braun von Reinersdorff, Bianka Knoblach & Dietmar Fink — Professional services as design imperatives for management consulting. Topics and success factors for consulting projects in the healthcare sector, with a focus on complementary consulting and digital transformation.
Integrated care | selective contracts as a driver of innovation?
BVMed
Dr Tino Schubert from LinkCare gave a lecture at the BVMed Academy on market access and reimbursement.
What I particularly appreciate about LinkCare is that they always come up with new and creative solutions for market access, always weigh up the options fairly and honestly together with us and then always implement the agreed projects within the specified timeframe and at the agreed cost on the basis of their professional project management. Our entire Terumo team really enjoys working with LinkCare. Keep up the good work!
Viktor Makowski
Market Access Manager DACH
Terumo Deutschland GmbH
Health networks
Susanne Eble & Clarissa Kurscheid — How a healthcare network is planned, designed and implemented - from strategy to operational management. With delegation models, structured treatment pathways and efficient practice processes in response to the changing expectations of young doctors.
Company portrait at the TOP CONSULTANT competition
Top Consultant
Our company portrait in the renowned TOP CONSULTANT competition.
LinkCare has an in-depth understanding of the German reimbursement system and the hurdles to overcome. They really develop practicable solutions for our sales force by transforming complex knowledge into an easy-to-use web-application. I can only recommend to get to know LinkCare.
André Roeder
Head Commercial Operations EU
TETEC AG
Long-term opioid therapy and mortality
BMC Medicine — Retrospective database study on chronic non-cancer pain: long-term opioid therapy was associated with higher all-cause mortality compared with non-opioid analgesics.
LinkCare is one of Germany's best SME consultancies
Handelsblatt
LinkCare is one of Germany's best SME consultancies: 2nd place in the TOP CONSULTANT Award 2025. In the Handelsblatt/Presseportal article, LinkCare GmbH is ranked 2nd among the award-winning consultancies in the "up to 10 employees" size category.
LinkCare is our long-standing partner in questions of reimbursement. For expanding our reimbursement in Switzerland, they provided an outstanding service; from coordinating with our KOLs, the medical associations and the BAG, to project management and writing the submission.
Ricardo Kloefkorn
Senior Market Access Manager
Therakos
Mortality from sepsis and septic shock
Critical Care — Systematic review and meta-analysis of 30- and 90-day mortality from sepsis and septic shock in Europe, North America and Australia between 2009 and 2019.
Leap to the top
Top Consultant
LinkCare GmbH has taken first place in the TOP CONSULTANT competition in size category A (up to ten employees). This means that since 15 June, the consultancy has not only been able to bear the TOP CONSULTANT seal, but also the title "Consultant of the Year®". For the 12th time, the nationwide TOP CONSULTANT competition analysed on a scientific basis how well the participants have advised their medium-sized clients.
The jury for the Top Consultant 2017 award at LinkCare recognised "the consultants' in-depth expertise and their pragmatic instinct for deriving business solutions."
Prof. Dr. Dietmar Fink
Wissenschaftliche Leitung
Beraterwettbewerb „Beste Mittelstandsberater"
Tomosynthesis in the early detection of breast cancer
European Radiology — Systematic review and meta-analysis of the combination of digital breast tomosynthesis and synthesised 2D mammography in comparison with conventional digital mammography.
Selective contracts with MedTech - an opportunity for the industry?
BVMed
As in the previous year, Dr Tino Schubert from LinkCare was a guest speaker at the BVMed Academy. This time on the topic: Selective contracts with MedTech - an opportunity for the industry? A case study with selected health insurance companies.
The comprehensible preparation of very complex issues and breaking them down to the essentials for me (the customer) is something that LinkCare has mastered like no other consultancy company in the industry that I know of to date.
TOP Consultant 2021
Kundenbefragung
2021
Guideline-based vs. high-dose opioid therapy
Pain — Retrospective cross-sectional study on the question of whether guideline-based long-term opioid therapy for chronic non-tumour-related pain is associated with better outcomes than high-dose therapy.
The specialist for the extraordinary
Top Consultant
Commitment, trust, consistency - these three values form the strong foundation and a key part of LinkCare GmbH's recipe for success. Based in Ludwigsburg and Berlin, the highly specialised, application-oriented consultancy serves a niche market with its health economics expertise: focusing on market access and healthcare research, the small team provides clients from the medical technology and pharmaceutical industries with comprehensive analyses and tailored recommendations for action.
The products that are sold are by no means run-of-the-mill, but rather customised to individual customer problems. You get the feeling that every little detail is important and is taken into account by LinkCare.
TOP Consultant 2019
Kundenbefragung
The healthcare situation for cirrhosis in Germany
Repräsentative Claims-Datenbank mit 4,9 Mio. gesetzlich Versicherten · Liver International — A longitudinal observational study on the prevalence, comorbidities, mortality, resource utilisation and costs associated with patients with cirrhosis in Germany.
LinkCare bears the TOP CONSULTANT seal 2025 - 2nd place in size class A
Top Consultant
LinkCare bears the TOP CONSULTANT seal 2025 and achieved 2nd place in size category A - The film about the award.
They are interested in long-term collaboration and don't just want a quick deal. We are very honest and open with each other.
TOP Consultant 2017
Kundenbefragung
2017
Cost-effectiveness of a novel cartilage cell therapy for cartilage defects in the knee
Journal of Medical Economics — Systematic review and meta-analysis: The study compares VABB and punch biopsy in cases of suspicious breast lesions and demonstrates advantages in terms of diagnostic certainty and a lower number of repeat biopsies.
Clients particularly appreciate the combination of analytical depth, honesty and pragmatic implementation, as well as the ability to find creative solutions quickly, even in complex situations.
TOP Consultant 2025
Juryfazit